Fisher & Paykel Healthcare Corporation Limited Stock

Equities

FPH

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

End-of-day quote New Zealand S.E. 06:00:00 2024-06-06 pm EDT 5-day change 1st Jan Change
30 NZD -1.64% Intraday chart for Fisher & Paykel Healthcare Corporation Limited +1.69% +27.12%
Sales 2025 * 1.96B 1.19B Sales 2026 * 2.18B 1.33B Capitalization 17.52B 10.7B
Net income 2025 * 340M 208M Net income 2026 * 410M 250M EV / Sales 2025 * 8.95 x
Net cash position 2025 * 9.71M 5.93M Net cash position 2026 * 16.62M 10.15M EV / Sales 2026 * 8.03 x
P/E ratio 2025 *
51.4 x
P/E ratio 2026 *
42.8 x
Employees 7,005
Yield 2025 *
1.46%
Yield 2026 *
1.64%
Free-Float 90.59%
More Fundamentals * Assessed data
Dynamic Chart
Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the Year 2025 CI
Fisher & Paykel Healthcare Corporation Limited Announces Final Dividend for the Full Year 2024, Payable on 10 July 2024 CI
Fisher & Paykel Healthcare Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
New Zealand Shares Flat; Fisher & Paykel Healthcare's Fiscal 2024 Net Profit Falls MT
Fisher & Paykel Healthcare's Net Profit Nearly Halves in Fiscal Year 2024; Shares Rise 6% MT
Transcript : Fisher & Paykel Healthcare Corporation Limited, 2024 Earnings Call, May 29, 2024
New Zealand Shares Fall for Second Day; Fisher & Paykel Healthcare Launches Apnea Mask MT
Fisher & Paykel Begins Selling Lightest Mask for Sleep Apnea MT
JPMorgan Upgrades Fisher & Paykel Healthcare to Neutral from Underweight; Price Target is NZ$24.00 MT
New Zealand Shares Jump on Rate Cut Hopes; WasteCo Raises NZ$3 Million from Convertible Bond Offer MT
Fisher & Paykel Issues Limited Recall of Airvo Devices; Flags NZ$12 Million Hit MT
Fisher & Paykel Healthcare Corporation Limited Initiates Voluntary Limited Recall of Airvo 2 and myAirvo 2 Devices Manufactured Before 14 August 2017 CI
Fisher & Paykel Healthcare Expects NZ$1.73 FY Billion Operating Revenue MT
Fisher & Paykel Healthcare Corporation Limited Revises Earnings Guidance for the Financial Year Ending 31 March 2024 CI
New Zealand Shares Jump on Friday, Fisher & Paykel Healthcare's Chair to Retire MT
More news

Latest transcript on Fisher & Paykel Healthcare Corporation Limited

1 day-1.64%
1 week+1.69%
Current month+1.69%
1 month+4.53%
3 months+20.58%
6 months+25.00%
Current year+27.12%
More quotes
1 week
29.06
Extreme 29.06
31.25
1 month
27.51
Extreme 27.51
31.25
Current year
22.55
Extreme 22.55
31.25
1 year
20.29
Extreme 20.29
31.25
3 years
18.02
Extreme 18.02
34.55
5 years
14.85
Extreme 14.85
37.89
10 years
4.51
Extreme 4.51
37.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 84-12-31
Director of Finance/CFO - 19-02-28
Chief Tech/Sci/R&D Officer - 14-07-31
Members of the board TitleAgeSince
Director/Board Member 66 90-04-30
Chairman - 15-09-30
Chief Executive Officer 63 84-12-31
More insiders
Date Price Change Volume
24-06-07 30 -1.64% 496,521
24-06-06 30.5 -2.40% 672,300
24-06-05 31.25 +3.82% 496,713
24-06-04 30.1 +2.03% 487,524

End-of-day quote New Zealand S.E., June 06, 2024

More quotes
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
30 NZD
Average target price
25.95 NZD
Spread / Average Target
-13.50%
Consensus